⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8548278 | 0.76 | — | — | |
| SCHEMBL7519779 | 0.75 | — | — | |
| SCHEMBL5962317 | 0.71 | CYP2C19 (0.34) | — | |
| SCHEMBL845998 | 0.67 | — | — | |
| SCHEMBL11271152 | 0.66 | CYP2C19 (0.31) | — | |
| SCHEMBL9089091 | 0.66 | CYP2C19 (0.31) | — | |
| SCHEMBL3084499 | 0.66 | CYP2C19 (0.39) | — | |
| SCHEMBL131709 | 0.62 | — | — | |
| SCHEMBL534090 | 0.62 | — | — | |
| SCHEMBL14272008 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107108602-B | Process for preparing thiazole derivatives | 协和麒麟株式会社 | 2021-08-03 | — | — | CN | disclosed |
| EP-3822269-A1 | PRODUCTION METHOD OF THIAZOLE DERIVATIVE | Kyowa Kirin Co., Ltd. (JP) | 2021-05-19 | — | — | EP | disclosed |
| US-10894790-B2 | Production method of thiazole derivative | KYOWA KIRIN CO., LTD (JP) | 2021-01-19 | — | — | US | disclosed |
| EP-3242877-B1 | PRODUCTION METHOD OF THIAZOLE DERIVATIVE | KYOWA KIRIN CO LTD (JP) | 2020-12-16 | — | — | EP | disclosed |
| US-20200247798-A1 | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | KYOWA KIRIN CO LTD (JP) | 2020-08-06 | — | — | US | disclosed |
| US-20200216438-A1 | PRODUCTION METHOD OF THIAZOLE DERIVATIVE | KYOWA KIRIN CO LTD (JP) | 2020-07-09 | — | — | US | disclosed |
| US-10618894-B2 | Production method of thiazole derivative | KYOWA KIRIN CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-10407440-B2 | Therapeutic agent for motor disorders | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2019-09-10 | — | — | US | disclosed |
| US-20190144438-A1 | PRODUCTION METHOD OF THIAZOLE DERIVATIVE | KYOWA KIRIN CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| EP-3378860-A1 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | Kyowa Hakko Kirin Co., Ltd. (JP) | 2018-09-26 | — | — | EP | disclosed |
| WO-2016111381-A1 | PRODUCTION METHOD OF THIAZOLE DERIVATIVE | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2016-07-14 | — | — | WO | disclosed |
| US-9249135-B2 | Therapeutic agent for mood disorders | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20150225417-A1 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | KYOWA KIRIN CO., LTD. (JP) | 2015-08-13 | — | — | US | disclosed |
| US-20150080415-A1 | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | KYOWA KIRIN CO., LTD. (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20120184554-A1 | THERAPEUTIC AGENT FOR MOOD DISORDERS | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| EP-2474544-A1 | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| EP-2474543-A1 | THERAPEUTIC AGENT FOR MOOD DISORDERS | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120172362-A1 | THERAPEUTIC AGENT FOR ANXIETY DISORDERS | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120101101-A1 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| EP-2433938-A1 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | Kyowa Hakko Kirin Co., Ltd. (JP) | 2012-03-28 | — | — | EP | disclosed |